All In MedTech

Device Trial Radar · NCT06009458

Acuity 200™ (Fluoroxyfocon A) Orthokeratology Contact Lens for Overnight Wear

Clinical Evaluation of Safety and Effectiveness for Acuity 200™ (Fluoroxyfocon A) Orthokeratology Contact Lens for Overnight Wear

Last checked: Nov 19, 2026Latest source record: Jan 14, 2025 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruiting

Status

Active, not recruiting

Enrollment

387

Actual

Start

Oct 1, 2023

Primary completion

Sep 2025

Study completion Sep 2025

Sponsor

Lead sponsor
Acuity Polymers, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Aug 24, 2023

More device trials from this sponsor

Design

Study type
Interventional
Phase
Not applicable (typical for device studies)
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated device
Yes
Who can join
All sexes, from 7 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The objective of this clinical investigation is to collect scientifically valid safety and effectiveness data on the Acuity 200™ (fluoroxyfocon A) Orthokeratology Contact Lens for Overnight Wear. The clinical performance data reported from this study is intended to be submitted to the U.S. Food and Drug Administration Center for Devices and Radiological Health (CDRH) in support of a new Premarket Application (PMA).

Conditions

  • Myopia

Interventions

  • Acuity 200™ (fluoroxyfocon A) Orthokeratology Contact Lens for Overnight WearDevice

    Acuity 200™ Orthokeratology Contact Lenses are intended to be worn overnight with removal during following day. The lenses are designed to produce a temporary reduction of myopia by reversibly altering the curvature of the cornea. The lenses are manufactured from fluoroxyfocon A, which is a gas permeable contact lens material composed of a siloxanyl fluoromethacrylate copolymer. The material name fluoroxyfocon A is registered with United States Adopted Name (USAN).The Acuity 200™ (fluoroxyfocon A) Orthokeratology Contact Lens is available in spherical, asymmetrical, aspheric, and tangential lens designs to best fit the individual cornea, using corneal topography and/or diagnostic lenses.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Lines of improvement of monocular UCVA at the 12-month visit (overall and stratified by baseline sphere)Time frame: 1 year
  2. Attempted vs. Achieved Reduction in manifest refractive errorTime frame: 1 Year
  3. Proportion of eyes achieved UCVA of ≤0.30 logMAR , ≤0.20 logMAR ,≤0.10 logMAR, and ≤0.00 logMARTime frame: 1 Year

5 more outcomes with a free account

Locations

13 sites in 3 countries. Site status is shown where the registry gives one.

  • Advanced Optometry of Mission Viejo

    Mission Viejo, California

  • Elsa Pao, O.D. Optometrist

    Oakland, California

  • Pacific Rims Optometry

    San Francisco, California

10 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.